Literature DB >> 32515234

A dynamic model of the opioid drug epidemic with implications for policy.

Jack Homer1, Wayne Wakeland2.   

Abstract

Background: The U.S. opioid epidemic has caused substantial harm for over 20 years. Policy interventions have had limited impact and sometimes backfired. Experts recommend a systems modeling approach to address the complexities of opioid policymaking.
Objectives: Develop a system dynamics simulation model that reflects the complexities and can anticipate intended and unintended intervention effects.
Methods: The model was developed from literature review and data gathering. Its outputs, starting in 1990, were compared against 12 historical time series. Four illustrative interventions were simulated for 2020-2030: reducing prescription dosage by 20%, cutting diversion by 30%, increasing addiction treatment from 45% to 65%, and increasing lay naloxone use from 4% to 20%. Sensitivity testing was performed to determine effects of uncertainties. No human subjects were studied.
Results: The model fits historical data well with error percentage averaging 9% across 201 data points. Interventions to reduce dosage and diversion reduce the number of persons with opioid use disorder (PWOUD) by 11% and 16%, respectively, but each of these interventions reduces overdoses by only 1%. Boosting treatment reduces overdoses by 3% but increases PWOUD by 1%. Expanding naloxone reduces overdose deaths by 12% but increases PWOUD by 2% and overdoses by 3%. Combining all four interventions reduces PWOUD by 24%, overdoses by 4%, and deaths by 18%. Uncertainties may affect these numerical results, but policy findings are unchanged.
Conclusion: No single intervention significantly reduces both PWOUD and overdose deaths, but a combination strategy can do so. Entering the 2020s, only protective measures like naloxone expansion could significantly reduce overdose deaths.

Entities:  

Keywords:  Opioid epidemic; fentanyl; historical time series; illicit market; naloxone; policy intervention; simulation model; system dynamics

Year:  2020        PMID: 32515234     DOI: 10.1080/00952990.2020.1755677

Source DB:  PubMed          Journal:  Am J Drug Alcohol Abuse        ISSN: 0095-2990            Impact factor:   3.829


  7 in total

1.  Effectiveness of Policies for Addressing the US Opioid Epidemic: A Model-Based Analysis from the Stanford-Lancet Commission on the North American Opioid Crisis.

Authors:  Isabelle J Rao; Keith Humphreys; Margaret L Brandeau
Journal:  Lancet Reg Health Am       Date:  2021-07-31

2.  Modeling the evolution of the US opioid crisis for national policy development.

Authors:  Tse Yang Lim; Erin J Stringfellow; Celia A Stafford; Catherine DiGennaro; Jack B Homer; Wayne Wakeland; Sara L Eggers; Reza Kazemi; Lukas Glos; Emily G Ewing; Calvin B Bannister; Keith Humphreys; Douglas C Throckmorton; Mohammad S Jalali
Journal:  Proc Natl Acad Sci U S A       Date:  2022-05-31       Impact factor: 12.779

3.  Data Needs in Opioid Systems Modeling: Challenges and Future Directions.

Authors:  Mohammad S Jalali; Emily Ewing; Calvin B Bannister; Lukas Glos; Sara Eggers; Tse Yang Lim; Erin Stringfellow; Celia A Stafford; Rosalie Liccardo Pacula; Hawre Jalal; Reza Kazemi-Tabriz
Journal:  Am J Prev Med       Date:  2020-12-01       Impact factor: 5.043

4.  Effects of Implementation and Enforcement Differences in Prescription Drug Monitoring Programs in 3 States: Connecticut, Kentucky, and Wisconsin.

Authors:  Julia Dickson-Gomez; Erika Christenson; Margaret Weeks; Carol Galletly; Jennifer Wogen; Antoinette Spector; Madelyn McDonald; Jessica Ohlrich
Journal:  Subst Abuse       Date:  2021-03-25

5.  Assessing the impact of the Good Samaritan Law in the state of Connecticut: a system dynamics approach.

Authors:  Nasim S Sabounchi; Rebekah Heckmann; Gail D'Onofrio; Jennifer Walker; Robert Heimer
Journal:  Health Res Policy Syst       Date:  2022-01-06

6.  Reducing opioid use disorder and overdose deaths in the United States: A dynamic modeling analysis.

Authors:  Erin J Stringfellow; Tse Yang Lim; Keith Humphreys; Catherine DiGennaro; Celia Stafford; Elizabeth Beaulieu; Jack Homer; Wayne Wakeland; Benjamin Bearnot; R Kathryn McHugh; John Kelly; Lukas Glos; Sara L Eggers; Reza Kazemi; Mohammad S Jalali
Journal:  Sci Adv       Date:  2022-06-24       Impact factor: 14.957

7.  Hepatitis C virus risk among young people who inject drugs.

Authors:  Pedro Mateu-Gelabert; Nasim S Sabounchi; Honoria Guarino; Courtney Ciervo; Kellie Joseph; Benjamin J Eckhardt; Chunki Fong; Shashi N Kapadia; Terry T K Huang
Journal:  Front Public Health       Date:  2022-07-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.